Pfizer (PFE) free cash flow was $9.1B in FY2025 (-8% YoY). The tables below show the complete quarterly and annual free cash flow history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Free Cash Flow
Fiscal Year
Free Cash Flow
YoY
2025
$9.1B
-8%
2024
$9.8B
+105%
2023
$4.8B
-82%
2022
$26.0B
-13%
2021
$29.9B
+157%
2020
$11.6B
+15%
2019
$10.1B
-26%
2018
$13.7B
-6%
2017
$14.6B
+3%
2016
$14.2B
+8%
2015
$13.2B
-15%
2014
$15.5B
-4%
2013
$16.2B
+6%
2012
$15.3B
-17%
2011
$18.4B
+85%
2010
$9.9B
-35%
2009
$15.4B
-7%
2008
$16.5B
+44%
2007
$11.5B
Recent Quarterly Free Cash Flow
Quarter
Free Cash Flow
Q2 2026
$302M
Q1 2026
$2.2B
Q4 2025
$4.5B
Q3 2025
$4.0B
Q2 2025
-$1.2B
Q1 2025
$1.8B
Q4 2024
$5.8B
Q3 2024
$6.1B
Q2 2024
-$2.4B
Q1 2024
$386M
Q4 2023
$4.2B
Q3 2023
$2.6B
Source: PFE on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.